JP2011504108A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011504108A5 JP2011504108A5 JP2010534507A JP2010534507A JP2011504108A5 JP 2011504108 A5 JP2011504108 A5 JP 2011504108A5 JP 2010534507 A JP2010534507 A JP 2010534507A JP 2010534507 A JP2010534507 A JP 2010534507A JP 2011504108 A5 JP2011504108 A5 JP 2011504108A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- phe
- fusion protein
- cancer
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 28
- 108020001507 fusion proteins Proteins 0.000 claims 11
- 102000037865 fusion proteins Human genes 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 102000039446 nucleic acids Human genes 0.000 claims 6
- 108020004707 nucleic acids Proteins 0.000 claims 6
- 150000007523 nucleic acids Chemical class 0.000 claims 6
- 208000015181 infectious disease Diseases 0.000 claims 5
- 230000001613 neoplastic effect Effects 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 4
- 230000002068 genetic effect Effects 0.000 claims 4
- 208000035473 Communicable disease Diseases 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 102100027581 Forkhead box protein P3 Human genes 0.000 claims 2
- 101710088098 Forkhead box protein P3 Proteins 0.000 claims 2
- 206010043276 Teratoma Diseases 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 208000003200 Adenoma Diseases 0.000 claims 1
- 206010001233 Adenoma benign Diseases 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 208000005440 Basal Cell Neoplasms Diseases 0.000 claims 1
- 206010004146 Basal cell carcinoma Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 241000711549 Hepacivirus C Species 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 claims 1
- 208000017604 Hodgkin disease Diseases 0.000 claims 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010024612 Lipoma Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000007256 Nevus Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000030852 Parasitic disease Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 101800001707 Spacer peptide Proteins 0.000 claims 1
- 208000002495 Uterine Neoplasms Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 230000004071 biological effect Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 201000011066 hemangioma Diseases 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 208000023525 immature teratoma Diseases 0.000 claims 1
- 230000001506 immunosuppresive effect Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000003834 intracellular effect Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 201000010260 leiomyoma Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000000289 malignant teratoma Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000000271 mature teratoma Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 208000008798 osteoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 208000003154 papilloma Diseases 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 208000017572 squamous cell neoplasm Diseases 0.000 claims 1
- 206010046766 uterine cancer Diseases 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP200703052 | 2007-11-19 | ||
| ES200703052A ES2328776B1 (es) | 2007-11-19 | 2007-11-19 | Peptidos con capacidad para unirse a escurfina y aplicaciones. |
| PCT/ES2008/000716 WO2009065982A1 (es) | 2007-11-19 | 2008-11-14 | Péptidos con capacidad para unirse a escurfina y aplicaciones |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011504108A JP2011504108A (ja) | 2011-02-03 |
| JP2011504108A5 true JP2011504108A5 (enExample) | 2012-01-12 |
| JP5385910B2 JP5385910B2 (ja) | 2014-01-08 |
Family
ID=40409793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010534507A Expired - Fee Related JP5385910B2 (ja) | 2007-11-19 | 2008-11-14 | スクルフィンに結合する能力を有するペプチドおよびその用途 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8524860B2 (enExample) |
| EP (1) | EP2223998B1 (enExample) |
| JP (1) | JP5385910B2 (enExample) |
| CN (1) | CN101903514B (enExample) |
| AU (1) | AU2008327792B2 (enExample) |
| BR (1) | BRPI0819311A2 (enExample) |
| CA (1) | CA2706201A1 (enExample) |
| ES (1) | ES2328776B1 (enExample) |
| MX (1) | MX2010005520A (enExample) |
| RU (1) | RU2502741C2 (enExample) |
| WO (1) | WO2009065982A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8080518B2 (en) * | 2007-12-05 | 2011-12-20 | Arbor Vita Corporation | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| CA3018494C (en) | 2009-06-10 | 2021-12-07 | Nono Inc. | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| CA2939711C (en) * | 2014-02-21 | 2020-09-29 | Cellectis | Method for in situ inhibition of regulatory t cells |
| ES2665543B1 (es) * | 2016-10-26 | 2019-02-12 | Fundacion Para La Investig Medica Aplicada | Péptidos de unión a FOXP3 y usos de los mismos |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698015A (en) * | 1995-05-19 | 1997-12-16 | Nikko Company | Conductor paste for plugging through-holes in ceramic circuit boards and a ceramic circuit board having this conductor paste |
| EP1037911A4 (en) * | 1997-12-10 | 2003-07-23 | Univ Washington | ANTI-PATHOGEN SYSTEM AND METHOD FOR USE THEREOF |
| ATE495255T1 (de) * | 1998-08-11 | 2011-01-15 | Darwin Discovery Ltd | Identifikation des gens das zum schorfigen phenotyp der maus führt, sowie seines menschlichen orthologs |
| WO2001059115A2 (en) * | 2000-02-09 | 2001-08-16 | Agensys, Inc. | 83p5g4: a tissue specific protein highly expressed in prostate cancer |
| US20030191073A1 (en) * | 2001-11-07 | 2003-10-09 | Challita-Eid Pia M. | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| ATE405586T1 (de) * | 2001-05-08 | 2008-09-15 | Darwin Molecular Corp | Verfahren zur regulierung der immunfunktion in primaten unter verwendung des foxp3-proteins |
| WO2006044864A2 (en) * | 2004-10-19 | 2006-04-27 | Duke University | Vaccine adjuvant |
| US20100061984A1 (en) * | 2006-01-20 | 2010-03-11 | The Trustees Of The University Of Pennsylvania | Compositions and methods for modulation of suppressor t cell activation |
-
2007
- 2007-11-19 ES ES200703052A patent/ES2328776B1/es not_active Expired - Fee Related
-
2008
- 2008-11-14 EP EP08852484.8A patent/EP2223998B1/en active Active
- 2008-11-14 WO PCT/ES2008/000716 patent/WO2009065982A1/es not_active Ceased
- 2008-11-14 MX MX2010005520A patent/MX2010005520A/es active IP Right Grant
- 2008-11-14 JP JP2010534507A patent/JP5385910B2/ja not_active Expired - Fee Related
- 2008-11-14 AU AU2008327792A patent/AU2008327792B2/en not_active Ceased
- 2008-11-14 US US12/743,616 patent/US8524860B2/en not_active Expired - Fee Related
- 2008-11-14 CN CN2008801217329A patent/CN101903514B/zh not_active Expired - Fee Related
- 2008-11-14 BR BRPI0819311-8A patent/BRPI0819311A2/pt not_active IP Right Cessation
- 2008-11-14 RU RU2010125199/10A patent/RU2502741C2/ru not_active IP Right Cessation
- 2008-11-14 CA CA2706201A patent/CA2706201A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017538682A5 (enExample) | ||
| JP2008538183A5 (enExample) | ||
| JP2010540453A5 (enExample) | ||
| JP2019512478A5 (enExample) | ||
| JP2008525033A5 (enExample) | ||
| FI3393510T3 (fi) | Zika-virusrokote | |
| JP2020525429A5 (enExample) | ||
| JP2006512300A5 (enExample) | ||
| JP2008505985A5 (enExample) | ||
| JP2012505657A5 (enExample) | ||
| JP2011504108A5 (enExample) | ||
| JP2001518304A5 (enExample) | ||
| JP2005502663A5 (enExample) | ||
| JP2014525939A5 (enExample) | ||
| JP2014510699A5 (enExample) | ||
| JP2011139704A5 (enExample) | ||
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| RU2010125199A (ru) | Пептиды со способностью связываться со скурфином и их применение | |
| JP2012512633A5 (enExample) | ||
| RU2010125695A (ru) | Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение | |
| CN105646626B (zh) | 一种高收率索氟布韦的合成方法 | |
| CN109415410B (zh) | 靶向树突细胞的肽、利用了该肽的肽融合体、及利用了该肽融合体的疫苗 | |
| JP2007511534A5 (enExample) | ||
| JP2011512336A5 (enExample) | ||
| US10662155B2 (en) | Methods of preparing tecovirimat |